Our US member organisation,the Lung Cancer Research Foundation (LCRF), recently named Dennis P. Chillemi as its new executive director.
LCRF is the largest lung cancer focused foundation in the US supporting lung cancer research. Its mission is to improve lung cancer outcomes by funding research for the prevention, diagnosis, treatment and cure of lung cancer.
Mr Chillemi most recently served as the senior director of development at the Lymphoma Research Foundation, where he was responsible for the development and implementation of national strategic plans for all fundraising activities, including corporate sponsorship, distinguished events and planned gifts.
Prior to joining the Lymphoma Research Foundation, Mr Chillemi served as the executive director of the Leukemia & Lymphoma Society’s Connecticut Westchester Hudson Valley Chapter, where he worked to implement new revenue streams and reduce expenses to improve organizational efficiencies and return on investment.
Mr Chillemi also founded two successful volunteer-led fundraising events that yielded more than $2.5 million in new revenue for the National Multiple Sclerosis Society and the Leukemia & Lymphoma Society. Mr. Chillemi’s management and administrative experience includes twenty-three years as a member of law enforcement, where he held a variety of positions and served two consecutive terms as an elected official in local government.
“Dennis’ expertise with nonprofit leadership, fundraising, and events makes him the ideal candidate for this position,” said Brendon M. Stiles, MD, LCRF Board Chair. “This is an exciting time for our organization and we are thrilled to have Dennis at the helm.”
In his role as executive director, Mr. Chillemi will focus on growing the impact of the organization on a national level, drive awareness and raise much needed funds to support cutting edge research in lung cancer.
“LCRF does incredible work in the lung cancer field, and I am honored to be joining as the new executive director of the organization,” said Mr. Chillemi. “I look forward to collaborating with the Board of Directors, staff and our incredible supporters as we work diligently to make an impact in the lives of those affected by lung cancer.”